British Society for Nanomedicine

§ September 24th, 2017 § Filed under Nano Medicine Comments Off on British Society for Nanomedicine

Welcome to the British Society for Nanomedicine

With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK

A new short course in nanotechnology is now available.

Only 14 places available so register soon.

What is Nanomedicine? Introducing applications of Nanotechnology

Saturday 12th May 2018

Nanomedicines are used globally to improve the lives of patients suffering from a range of disorders including cancer and various infectious diseases. Nanomedicines currently used clinically have overcome a number of issues associated with conventional drug delivery. This interactive workshop will introduce key areas in the development of nanomedicines. The course is presented by multidisciplinary researchers, with expertise in formulation, clinical application, and safety. Additionally, there will be the opportunity to discuss careers in academia. This course would benefit anyone with a general interest in current healthcare research.

University of Liverpool, 126 Mount Pleasant, L69 3GR

Presented by Dr Paul Curley, Dr James Hobson & Dr Neill Liptrott

Click here for more information

To see some of the presentations from this year's European Nanomedicine Meeting in London click on the presenter's name below:

Patrick Boisseau, ETPN, France

Nathalie Mignet, The French Society for Nanomedicine (SFNano)

Ulf Andersson, Chairman Nanomed North

Annette Bramley, EPSRC

Mark Platt, Loughborough University

Sylwia Sekula-Neuner, Karlsruhe Institute of Technology

Lea Ann Dailey, KCL, UK

Sven Even Borgos, SINTEF, Norway

Maria de la Fuente, Health Research Institute of Santiago de Compostela (IDIS), Spain

Klaus Weltring, German Platform NanoBioMedicine

Bassem Sabagh, PostNova

Editors-in-Chief Steve Rannard, Raj Bawa, Si-Shen Feng and Andrew Owen

The Journal of Interdisciplinary Nanomedicine (JOIN) is an international peer-reviewed academic journal that aims to provide truly interdisciplinary nanomedicine research. JOIN is now accepting submissions from all relevant fields to be included in the first issue.

The journal contains evidence-based research and translational outputs with high-level contributions from at least two sciences that are peer-reviewed by multiple reviewers tasked to focus primarily on their specialist areas. Multiple first and/or corresponding author status is encouraged so as to provide transparency and acknowledgment for contribution to multidisciplinary work. The Journal embraces submissions from all relevant fields as applied to early stage scientific developments and studies aimed at the progression of nanomedicines towards the clinic, which include engineering, science and medicine, especially materials sciences, life science, clinical science, intellectual property, regulatory issues and policy considerations. JOIN contains original research papers, editorials, review articles, technical notes, and letters to the editor about matters that may benefit the wider readership. Advances that are progressing to application through consolidation of multiple areas of expertise are especially encouraged. Core areas of particular interest include applications of new materials and biological concepts, targeted delivery, molecular biomaterials and nanotechnology in diagnostics, pharmacology, pharmaceutics, toxicology, and clinical outcomes.

For further details please lookhere

Continued here:
British Society for Nanomedicine

Comments are closed.